Alyref-flox Mouse
一般名
Alyref-flox
製品ID
S-CKO-06045
背景情報
C57BL/6NCya
系統ID
CKOCMP-21681-Alyref-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Alyref-flox Mouse（カタログ番号S-CKO-06045）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Alyref-flox
系統ID
CKOCMP-21681-Alyref-B6N-VA
遺伝子名
製品ID
S-CKO-06045
遺伝子別名
Aly, Ref1, Ref1-I, Refbp1, Tho4, Thoc4
遺伝子別名
C57BL/6NCya
遺伝子正式名称
Aly/REF export factor
NCBI ID
修正
Conditional knockout
染色体
Chr 11
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000026125
NCBIトランスクリプトID
NM_011568
ターゲット領域
Exon 3
有効領域の大きさ
~0.8 kb
遺伝子研究の概要
ALYREF, also known as Aly/REF export factor, is an RNA-binding protein. It plays key roles in mRNA export, pre-mRNA processing and mRNA stability regulation. It is associated with the 5-methylcytosine (m5C) modification pathway in mRNA metabolism, which is crucial for various biological processes [2,3].
In cancer research, ALYREF has been found to have significant impacts. In bladder cancer, ALYREF stabilizes PKM2 mRNA by binding to its m5C sites in 3'-untranslated regions, promoting cell proliferation via PKM2-mediated glycolysis. High ALYREF expression predicts poor survival in bladder cancer patients, and hypoxia-inducible factor-1alpha (HIF-1α) can up-regulate PKM2 expression indirectly through ALYREF activation [1].
In urothelial bladder cancer, ALYREF enhances cell proliferation and invasion in an m5C-dependent manner, by specifically binding to hypermethylated m5C sites in RABL6 and TK1 mRNA, promoting their splicing and stabilization. High co-expression of ALYREF/RABL6/TK1 axis is associated with poor overall survival [5].
In non-small cell lung cancer, LINC02159 binds to ALYREF to enhance the stability of YAP1 mRNA via m5C modification, promoting cancer progression [4].
In colorectal cancer, ALYREF forms a complex with ELAVL1 to promote m5C recognition and nuclear export of RPS6KB2 and RPTOR mRNAs, supporting cancer growth and migration, and high ALYREF protein expression predicts poor prognosis [6].
In nasopharyngeal carcinoma, ALYREF up-regulates NOTCH1 expression by enhancing its RNA stability in an m5C-modification-dependent manner, promoting cancer metastasis [7].
In breast cancer, high ALYREF expression is associated with poor prognosis, and ALYREF promotes cancer cell viability and decreases apoptosis by regulating EZH2 [8].
In conclusion, ALYREF is essential for mRNA-related regulatory processes. Through gene-knockout or conditional-knockout mouse models and in vivo studies in cancer research, ALYREF has been shown to play important roles in various cancer-related biological processes such as cell proliferation, invasion, and metastasis. Understanding ALYREF's functions provides potential therapeutic targets for multiple cancers.
References：
1. Wang, Jing-Zi, Zhu, Wei, Han, Jie, Wei, Ji-Fu, Yang, Haiwei. 2021. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. In Cancer communications (London, England), 41, 560-575. doi:10.1002/cac2.12158. https://pubmed.ncbi.nlm.nih.gov/33991457/
2. Yang, Xin, Yang, Ying, Sun, Bao-Fa, Sun, Ying-Pu, Yang, Yun-Gui. 2017. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m5C reader. In Cell research, 27, 606-625. doi:10.1038/cr.2017.55. https://pubmed.ncbi.nlm.nih.gov/28418038/
3. Zhao, Yan, Xing, Cheng, Peng, Hongling. 2023. ALYREF (Aly/REF export factor): A potential biomarker for predicting cancer occurrence and therapeutic efficacy. In Life sciences, 338, 122372. doi:10.1016/j.lfs.2023.122372. https://pubmed.ncbi.nlm.nih.gov/38135116/
4. Yang, Qiurong, Wang, Maoye, Xu, Jing, Gu, Jianmei, Zhang, Xu. 2023. LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling. In Molecular cancer, 22, 122. doi:10.1186/s12943-023-01814-x. https://pubmed.ncbi.nlm.nih.gov/37537569/
5. Wang, Ning, Chen, Ri-Xin, Deng, Min-Hua, Liu, Zhuo-Wei, Zhou, Fang-Jian. 2023. m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization. In Cell death & disease, 14, 139. doi:10.1038/s41419-023-05661-y. https://pubmed.ncbi.nlm.nih.gov/36806253/
6. Zhong, Longhua, Wu, Jingxun, Zhou, Bingqian, Ye, Feng, Lin, Xiaoting. 2024. ALYREF recruits ELAVL1 to promote colorectal tumorigenesis via facilitating RNA m5C recognition and nuclear export. In NPJ precision oncology, 8, 243. doi:10.1038/s41698-024-00737-0. https://pubmed.ncbi.nlm.nih.gov/39455812/
7. Jin, Yanan, Yao, Jijin, Fu, Jianchang, Xia, Tianliang, Xia, Liangping. 2024. ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA. In Cell death & disease, 15, 578. doi:10.1038/s41419-024-06959-1. https://pubmed.ncbi.nlm.nih.gov/39117671/
8. Jeong, Su-Jin, Oh, Ji Hoon, Cho, Je-Yoel. 2024. ALYREF enhances breast cancer progression by regulating EZH2. In Heliyon, 10, e37749. doi:10.1016/j.heliyon.2024.e37749. https://pubmed.ncbi.nlm.nih.gov/39386827/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。